| Target Price | $6.12 |
| Price | $2.52 |
| Potential |
142.86%
register free of charge
|
| Number of Estimates | 11 |
|
11 Analysts have issued a price target Zentalis Pharmaceuticals Inc 2027 .
The average Zentalis Pharmaceuticals Inc target price is $6.12.
This is
142.86%
register free of charge
$10.50
316.67%
register free of charge
$4.04
60.32%
register free of charge
|
|
| A rating was issued by 16 analysts: 10 Analysts recommend Zentalis Pharmaceuticals Inc to buy, 6 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Zentalis Pharmaceuticals Inc stock has an average upside potential 2027 of
142.86%
register free of charge
|
| Analyst | Rating | Action | Date |
|---|---|---|---|
| William Blair |
Locked
➜
Locked
|
Locked | Sep 16 2026 |
| Rodman & Renshaw |
Locked
➜
Locked
|
Locked | Jul 23 2026 |
| Mizuho |
Locked
➜
Locked
|
Locked | Jul 17 2026 |
| Guggenheim |
Locked
➜
Locked
|
Locked | Apr 10 2026 |
| Guggenheim |
Locked
➜
Locked
|
Locked | Mar 27 2026 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Nov 12 2025 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | Aug 07 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
William Blair:
Locked
➜
Locked
|
Sep 16 2026 |
|
Locked
Rodman & Renshaw:
Locked
➜
Locked
|
Jul 23 2026 |
|
Locked
Mizuho:
Locked
➜
Locked
|
Jul 17 2026 |
|
Locked
Guggenheim:
Locked
➜
Locked
|
Apr 10 2026 |
|
Locked
Guggenheim:
Locked
➜
Locked
|
Mar 27 2026 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Nov 12 2025 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Aug 07 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


